Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa.
about
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.Treatment of Pseudomonas aeruginosa infection in critically ill patients.Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections.Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam.Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis.Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.Impact of sample size on the performance of multiple-model pharmacokinetic simulations.Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children.Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulationsCorrelation of pharmacokinetic/pharmacodynamic-derived predictions of antibiotic efficacy with clinical outcomes in severely ill patients with Pseudomonas aeruginosa pneumonia.Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.Therapeutic Drug Monitoring of Prolonged Infusion Aztreonam for Multi-Drug Resistant Pseudomonas aeruginosa: A Case Report.Integrated pharmacokinetic-pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
P2860
Q36287127-3AEA5B78-0DC7-42F3-9404-9E8F30F7457FQ36582692-76D15E6E-45CB-43E0-BD65-51CA4BD10C41Q36607415-59E8E297-8614-4734-AB9B-688BD225F918Q36652824-AFAD742A-336C-4F1F-95DE-E77C00BB00E0Q36969880-19AC15AC-316B-4001-B35F-7B8FBD4FBF04Q37079350-3F2EAAB2-2B1A-49C8-8245-941CC8F0C826Q38073197-A14B2E5C-131D-4556-B507-0D878243E36CQ38110142-463D9FF1-21B8-4A54-A696-75C3102995CCQ38167345-1457980C-6E97-4017-A215-B8160E19ABA2Q38313276-86D43682-FD67-4A66-AB92-F1434C8D2C16Q39078075-CF0FBC65-2594-4310-98C8-D894B79A7CF2Q40186288-128D2343-87EF-4549-9F19-9E3DD5D843EAQ41455396-44F083EF-D2AB-496E-9DA3-F28C4497D054Q42006135-A1FC48CD-0A01-4270-A97C-3EE7752C3049Q42259839-7250C01B-9BD5-43D6-9885-0337265F026CQ43153489-F7B92144-2C7D-4105-9905-0EE929F1362BQ47146451-87474DDB-177A-4383-83C4-6AAE230C05C2Q57491074-653BC076-AF8B-4D94-BC83-BD8EC94D2AEE
P2860
Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@ast
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@en
type
label
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@ast
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@en
prefLabel
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@ast
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@en
P2093
P2860
P921
P1433
P1476
Integration of population phar ...... gainst Pseudomonas aeruginosa.
@en
P2093
Arnold Louie
Ben M Lomaestro
George L Drusano
Vincent H Tam
P2860
P304
P356
10.1592/PHCO.23.3.291.32110
P407
P577
2003-03-01T00:00:00Z